Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 3
2013 3
2014 4
2015 5
2016 2
2018 5
2019 6
2020 5
2021 5
2022 6
2023 10
2024 10
2025 20
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean lundberg dp[Author] (2 results)?
Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies.
Li H, Zandberg DP, Kulkarni A, Chiosea SI, Santos PM, Isett BR, Joy M, Sica GL, Contrera KJ, Tatsuoka CM, Brand M, Duvvuri U, Kim S, Kubik M, Sridharan S, Tu F, Chen J, Bruno TC, Vignali DAA, Cillo AR, Bao R, Wang JH, Vujanovic L, Ferris RL. Li H, et al. Among authors: zandberg dp. Cancer Cell. 2025 Apr 14;43(4):757-775.e8. doi: 10.1016/j.ccell.2025.02.026. Epub 2025 Mar 13. Cancer Cell. 2025. PMID: 40086437 Free PMC article. Clinical Trial.
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).
Cohen EEW, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL, Licitra L, Mehanna H, Mell LK, Raben A, Sikora AG, Uppaluri R, Whitworth F, Zandberg DP, Ferris RL. Cohen EEW, et al. Among authors: zandberg dp. J Immunother Cancer. 2019 Jul 15;7(1):184. doi: 10.1186/s40425-019-0662-5. J Immunother Cancer. 2019. PMID: 31307547 Free PMC article.
Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancer.
Doerfler R, Chen J, Kim C, Smith JD, Harris M, Singh KB, Isett B, Dadey RE, Brown DD, Lee AV, Wang X, Spector ME, Kim S, Sridharan S, Contrera K, Smith K, Reeder C, Lyons M, Luo J, Liu S, Zandberg DP, Skinner HD, Zervantonakis IK, Vujanović L, Ferris RL, Seethala RR, Zevallos JP, Luke JJ, Bao R. Doerfler R, et al. Among authors: zandberg dp. Oral Oncol. 2025 Dec;171:107742. doi: 10.1016/j.oraloncology.2025.107742. Epub 2025 Nov 9. Oral Oncol. 2025. PMID: 41213213 Free PMC article.
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations.
Nguyen MK, Jelinek M, Singh A, Isett B, Myers ES, Mullett SJ, Eisele Y, Beumer J, Parise R, Urban J, Rose A, Sellitto L, Singh K, Doerfler R, Dadey RE, Kim C, Rhee JC, Davar D, Villaruz LC, Burgess M, Drappatz J, Mantica M, Goodman AE, Wang H, Singhi AD, Luke JJ, Zandberg DP, Bao R. Nguyen MK, et al. Among authors: zandberg dp. medRxiv [Preprint]. 2025 Jul 21:2025.07.19.25331848. doi: 10.1101/2025.07.19.25331848. medRxiv. 2025. Update in: Oncologist. 2025 Nov 11;30(11):oyaf362. doi: 10.1093/oncolo/oyaf362. PMID: 40778139 Free PMC article. Updated. Preprint.
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations.
Nguyen MK, Jelinek M, Singh A, Isett B, Myers ES, Mullett SJ, Eisele Y, Beumer JH, Parise RA, Urban J, Rose A, Sellitto L, Singh K, Doerfler R, Dadey RE, Kim C, Rhee JC, Davar D, Villaruz LC, Burgess M, Drappatz J, Mantica M, Goodman AE, Wang H, Singhi AD, Luke JJ, Zandberg DP, Bao R. Nguyen MK, et al. Among authors: zandberg dp. Oncologist. 2025 Nov 11;30(11):oyaf362. doi: 10.1093/oncolo/oyaf362. Oncologist. 2025. PMID: 41138165 Free PMC article. Clinical Trial.
Phase I Clinical Trial of the Bifunctional EGFR/TGF-β Fusion Protein Ficerafusp Alfa (BCA101) Alone and in Combination with Pembrolizumab for Advanced Solid Tumors.
Hernando-Calvo A, Carvajal RD, Paik PK, Morris VK, Zandberg DP, Kaczmar JM, Bohr DN, Reiners RD, Gharakhani E, Salazar RL, Lizotte PH, Ivanova EV, Bedard PL, Hanna GJ. Hernando-Calvo A, et al. Among authors: zandberg dp. Clin Cancer Res. 2025 Nov 14;31(22):4623-4632. doi: 10.1158/1078-0432.CCR-25-0100. Clin Cancer Res. 2025. PMID: 40643947 Free PMC article. Clinical Trial.
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma.
Zandberg DP, Allred JB, Rosenberg AJ, Kaczmar JM, Swiecicki P, Julian RA, Poklepovic AS, Bauman JR, Phan MD, Saba NF, Rivera E, Rowland K, Davar D, Cordes J, Ho AL, Zhang M, Berg SA, Munster PN, Schwartz GK. Zandberg DP, et al. J Clin Oncol. 2025 Jul 20;43(21):2398-2408. doi: 10.1200/JCO-25-00759. Epub 2025 May 31. J Clin Oncol. 2025. PMID: 40448574 Free PMC article. Clinical Trial.
78 results